Exclusive: Trial of Gilead’s potential coronavirus treatment running ahead of schedule, researcher says (Reuters)

Reuters: Exclusive: Trial of Gilead’s potential coronavirus treatment running ahead of schedule, researcher says. “Remdesivir has drawn tremendous attention as a therapy with the potential to alter the course of the disease, based on anecdotal reports that it may have helped some patients. Those hopes were dampened somewhat on Thursday, when details from a Chinese remdesivir trial in patients with severe COVID-19 inadvertently released by the World Health Organization suggested it provided no benefit. Gilead pushed back on that interpretation saying the study, which was stopped early due to low patient enrollment, cannot provide meaningful conclusions.”

%d bloggers like this: